Calcium‐Activated Neutral Proteinase (Calpain) System in Aging and Alzheimer's Diseasea
- 17 December 1994
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 747 (1) , 77-91
- https://doi.org/10.1111/j.1749-6632.1994.tb44402.x
Abstract
Calpains (CANPs) are a family of calcium-dependent cysteine proteases under complex cellular regulation. By making selective limited proteolytic cleavages, they activate or alter the regulation of certain enzymes, including key protein kinases and phosphatases, and induce specific cytoskeletal rearrangements, accounting for their suspected involvement in intracellular signaling, vesicular trafficking, and structural stabilization. Calpain activity has been implicated in various aging phenomena, including cataract formation and erythrocyte senescence. Abnormal activation of the large stores of latent calpain in neurons induces cell injury and is believed to underlie neurodegeneration in excitotoxicity, Wallerian degeneration, and certain other neuropathologic states involving abnormal calcium influx. In Alzheimer's disease, we found the ratio of activated calpain I to its latent precursor isoform in neocortex to be threefold higher than that in normal individuals and those with Huntington's or Parkinson's disease. Immunoreactivity toward calpastatin, the endogenous inhibitor of calpain, was also markedly reduced in layers II-V of the neocortex in Alzheimer's disease. The excessive calpain system activation suggested by these findings represents a potential molecular basis for synaptic loss and neuronal cell death in the brain in Alzheimer's disease given the known destructive actions of calpain I and its preferential neuronal and synaptic localization. In surviving cells, persistent calpain activation may also contribute to neurofibrillary pathology and abnormal amyloid precursor protein trafficking/processing through its known actions on protein kinases and the membrane skeleton. The degree of abnormal calpain activation in the brain in Alzheimer's disease strongly correlated with the extent of decline in levels of secreted amyloid precursor protein in brain. Cytoskeletal proteins that are normally good calpain substrates become relatively calpain resistant when they are hyperphosphorylated, which may contribute to their accumulation in neurofibrillary tangles. As a major effector of calcium signals, calpain activity may mirror disturbances in calcium homeostasis and mediate important pathologic consequences of such disturbances.Keywords
This publication has 114 references indexed in Scilit:
- Cytoskeletal proteolysis during calcium-induced morphological transitions of human erythrocytesExperimental Cell Research, 1992
- Specific increase in calcium-activated neutral protease with low calcium sensitivity (m-calpain) in proerythroblastic K562 cell line cells induced to differentiation by phorbol 12-myristate 13-acetateExperimental Cell Research, 1992
- Glutamate Neurotoxicity Is Independent of Calpain I Inhibition in Primary Cultures of Cerebellar Granule CellsJournal of Neurochemistry, 1991
- Demonstration of neurofibrillary tangles in parvalbumin-immunoreactive interneurones in the cerebral cortex of Alzheimer-type dementia brainNeuroscience Letters, 1991
- Calpain II-dependent solubilization of a nuclear protein kinase at micromolar calcium concentrationsBiochemical and Biophysical Research Communications, 1990
- Regulation of the calcium-activated neutral proteinase (CANP) of bovine brain by myelin lipidsBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1990
- Neuron-specific and state-specific differences in calcium homeostasis regulate the generation and degeneration of neuronal architectureNeuron, 1990
- The Ca2+-activated protease (calpain) modulates Ca2+/calmodulin dependent activity of smooth muscle myosin light chain kinaseBiochemical and Biophysical Research Communications, 1987
- Role of Ca2+ and Ca2+-activated protease in myoblast fusionExperimental Cell Research, 1986
- Platelet Ca2+-activated, phospholipid-dependent protein kinase: Evidence for proteolytic activation of the enzyme in cells treated with phospholipase CBiochemical and Biophysical Research Communications, 1984